Search

Your search keyword '"Kim, Kyung Soo"' showing total 2,500 results

Search Constraints

Start Over You searched for: Author "Kim, Kyung Soo" Remove constraint Author: "Kim, Kyung Soo"
2,500 results on '"Kim, Kyung Soo"'

Search Results

3. A Compact Optical Six-Axis Force/Torque Sensor for Legged Robots Using a Polymorphic Calibration Method

5. Prediction of TKI response in EGFR-mutant lung cancer patients-derived organoids using malignant pleural effusion

6. DualRefine: Self-Supervised Depth and Pose Estimation Through Iterative Epipolar Sampling and Refinement Toward Equilibrium

7. Lightweight HDR Camera ISP for Robust Perception in Dynamic Illumination Conditions via Fourier Adversarial Networks

8. DGSS : Domain Generalized Semantic Segmentation using Iterative Style Mining and Latent Representation Alignment

11. Correction: Cancer organoid-based diagnosis reactivity prediction (CODRP) index-based anticancer drug sensitivity test in ALK-rearrangement positive non-small cell lung cancer (NSCLC)

12. Cancer organoid-based diagnosis reactivity prediction (CODRP) index-based anticancer drug sensitivity test in ALK-rearrangement positive non-small cell lung cancer (NSCLC)

15. Correlate-and-Excite: Real-Time Stereo Matching via Guided Cost Volume Excitation

19. Evaluating COPY-BLEND Augmentation for Low Level Vision Tasks

20. Towards Domain Invariant Single Image Dehazing

22. Retaining Image Feature Matching Performance Under Low Light Conditions

27. Output feedback based event-triggered sliding mode control for delta operator systems

29. Efficacy and safety of enavogliflozin versus dapagliflozin added to metformin plus gemigliptin treatment in patients with type 2 diabetes: a double-blind, randomized, comparator-active study: ENHANCE-D study

37. Coupled fixed point theorems under new coupled implicit relation in Hilbert spaces

39. Fenofibrate and risk of end‐stage renal disease: A nationwide cohort study.

40. Long‐term efficacy and safety of enavogliflozin in Korean people with type 2 diabetes: A 52‐week extension of a Phase 3 randomized controlled trial.

Catalog

Books, media, physical & digital resources